Ilaria Ferlenghi
Associate Director, Senior Scientific Leader Protein Structure & Biochemistry, Vx Discovery Tech GSK
As a Senior R&D leader, I have successfully navigated the dynamic landscape of Vaccine Research and Development. My track record demonstrates strategic planning, execution, and the introduction of innovative approaches and novel concepts to support business goals. My expertise lies at the intersection of Structural Biology and AI/ML, where I’ve driven breakthroughs that advance vaccine discovery and development. Excellent organizational, coordination and interpersonal skills. Proactive self-starter.
Seminars
Wednesday 13th January 2027
Panel Discussion: Expanding the Druggable Universe & the Future of Rational Drug Design in an Era of AI, Structural Biology & Emerging Modalities
9:00 am
- Explore why complex, dynamic, and previously inaccessible targets have challenged traditional drug discovery approaches
- Discover how advances in structural biology, biophysics, computational chemistry, and AI are expanding the druggable proteome
- Understand how molecular glues, degraders, and other emerging modalities reshaping discovery portfolios are and required capabilities
- Identify which technologies are driving value today versus those likely to transform discovery over the next decade
- Learn how leading organisations are combining experimental and computational approaches to pursue challenging targets with greater confidence
Thursday 14th January 2027
Combining Structural Biology, Biophysics & AI to Create Better Therapeutics Faster
9:00 am
- Integrate structural, biophysical, and computational data to improve decision-making and accelerate candidate progression
- Leverage AI-powered predictions alongside experimental validation to identify high-quality drug candidates with greater confidence
- Discover how leading organisations are reducing discovery timelines by combining orthogonal technologies across the drug design process
